The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background:Although lymphoid malignancies are generallychemosensitive, relapse is common. The use of high-dose therapy can makesubsequent cytotoxic therapy intolerable. There is a need to develop regimenswith low acute toxicity which are suitable for use in patients post-high dosetherapy and following the failure of standard protocols. Patients and methods:Twenty-six patients with lymphomas, fifteenof...
Introduction: Since 1995, the European Association of Pathologists (EAHP) and the Society for Hematopathology (SH) have been developing a new World Health Organization (WHO) Classification of hematologic malignancies. The classification includes lymphoid, myeloid, histiocytic, and mast cell neoplasms. Design: The WHO project involves 10 committees of pathologists, who have developed lists and definitions...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.